These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 26654849)

  • 1. The Ups and Downs of Genetic Diagnosis of Hypertrophic Cardiomyopathy.
    Gómez J; Reguero JR; Coto E
    Rev Esp Cardiol (Engl Ed); 2016 Jan; 69(1):61-8. PubMed ID: 26654849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening of MYH7, MYBPC3, and TNNT2 genes in Brazilian patients with hypertrophic cardiomyopathy.
    Marsiglia JD; Credidio FL; de Oliveira TG; Reis RF; Antunes Mde O; de Araujo AQ; Pedrosa RP; Barbosa-Ferreira JM; Mady C; Krieger JE; Arteaga-Fernandez E; Pereira Ada C
    Am Heart J; 2013 Oct; 166(4):775-82. PubMed ID: 24093860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Genetic tests in hypertrophic cardiomyopathy: Benefits, limitations, and applications in clinical practice].
    Gómez Arraiz I; Barrio Ollero E; Gómez Peligros A
    Semergen; 2018 Oct; 44(7):485-491. PubMed ID: 29858109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel Phenotype-Genotype Correlations of Restrictive Cardiomyopathy With Myosin-Binding Protein C (MYBPC3) Gene Mutations Tested by Next-Generation Sequencing.
    Wu W; Lu CX; Wang YN; Liu F; Chen W; Liu YT; Han YC; Cao J; Zhang SY; Zhang X
    J Am Heart Assoc; 2015 Jul; 4(7):. PubMed ID: 26163040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetics of hypertrophic cardiomyopathy after 20 years: clinical perspectives.
    Maron BJ; Maron MS; Semsarian C
    J Am Coll Cardiol; 2012 Aug; 60(8):705-15. PubMed ID: 22796258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A molecular screening strategy based on beta-myosin heavy chain, cardiac myosin binding protein C and troponin T genes in Italian patients with hypertrophic cardiomyopathy.
    Girolami F; Olivotto I; Passerini I; Zachara E; Nistri S; Re F; Fantini S; Baldini K; Torricelli F; Cecchi F
    J Cardiovasc Med (Hagerstown); 2006 Aug; 7(8):601-7. PubMed ID: 16858239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic diagnosis of hypertrophic cardiomyopathy using mass spectrometry DNA arrays and high resolution melting.
    Santos S; Lança V; Oliveira H; Branco P; Silveira L; Marques V; Brito D; Madeira H; Bicho M; Fernandes AR
    Rev Port Cardiol; 2011 Jan; 30(1):7-18. PubMed ID: 21425739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA sequence capture and next-generation sequencing for the molecular diagnosis of genetic cardiomyopathies.
    D'Argenio V; Frisso G; Precone V; Boccia A; Fienga A; Pacileo G; Limongelli G; Paolella G; Calabrò R; Salvatore F
    J Mol Diagn; 2014 Jan; 16(1):32-44. PubMed ID: 24183960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Comparison of Whole Genome Sequencing to Multigene Panel Testing in Hypertrophic Cardiomyopathy Patients.
    Cirino AL; Lakdawala NK; McDonough B; Conner L; Adler D; Weinfeld M; O'Gara P; Rehm HL; Machini K; Lebo M; Blout C; Green RC; MacRae CA; Seidman CE; Ho CY;
    Circ Cardiovasc Genet; 2017 Oct; 10(5):. PubMed ID: 29030401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determining pathogenicity of genetic variants in hypertrophic cardiomyopathy: importance of periodic reassessment.
    Das K J; Ingles J; Bagnall RD; Semsarian C
    Genet Med; 2014 Apr; 16(4):286-93. PubMed ID: 24113344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Pathogenic Galactosidase A Mutation Coexisting With an MYBPC3 Mutation in a Female Patient With Hypertrophic Cardiomyopathy.
    Vitale G; Pasquale F; Leone O; Cenacchi G; Niro F; Torrado M; Maneiro E; Graziosi M; Ditaranto R; Capelli I; Monserrat L; Rapezzi C; Biagini E
    Can J Cardiol; 2020 Sep; 36(9):1554.e1-1554.e3. PubMed ID: 32710830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a novel MYBPC3 gene variant in a patient with hypertrophic cardiomyopathy.
    Brion M; Allegue C; Gil R; Blanco-Verea A; Carracedo A; Pagannone E; Evangelista A; Di Castro S; Marchitti S; Stanzione R; Volpe M; Rubattu S
    Ann Clin Lab Sci; 2010; 40(3):285-9. PubMed ID: 20689143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening of the
    Gómez J; Lorca R; Reguero JR; Morís C; Martín M; Tranche S; Alonso B; Iglesias S; Alvarez V; Díaz-Molina B; Avanzas P; Coto E
    Circ Cardiovasc Genet; 2017 Apr; 10(2):. PubMed ID: 28356264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel pathogenic variant of MYBPC3 responsible for hypertrophic cardiomyopathy.
    Yang X; Li Z; Wang Q; Zhang Y; Zhao C
    Cardiol Young; 2022 Apr; 32(4):539-544. PubMed ID: 34180388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic basis of hypertrophic cardiomyopathy in children.
    Rupp S; Felimban M; Schänzer A; Schranz D; Marschall C; Zenker M; Logeswaran T; Neuhäuser C; Thul J; Jux C; Hahn A
    Clin Res Cardiol; 2019 Mar; 108(3):282-289. PubMed ID: 30105547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted next-generation sequencing (NGS) of nine candidate genes with custom AmpliSeq in patients and a cardiomyopathy risk group.
    Glotov AS; Kazakov SV; Zhukova EA; Alexandrov AV; Glotov OS; Pakin VS; Danilova MM; Poliakova IV; Niyazova SS; Chakova NN; Komissarova SM; Kurnikova EA; Sarana AM; Sherbak SG; Sergushichev AA; Shalyto AA; Baranov VS
    Clin Chim Acta; 2015 Jun; 446():132-40. PubMed ID: 25892673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sarcomeric hypertrophic cardiomyopathy: genetic profile in a Portuguese population.
    Brito D; Miltenberger-Miltenyi G; Vale Pereira S; Silva D; Diogo AN; Madeira H
    Rev Port Cardiol; 2012 Sep; 31(9):577-87. PubMed ID: 22857948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Double heterozygosity for mutations in the beta-myosin heavy chain and in the cardiac myosin binding protein C genes in a family with hypertrophic cardiomyopathy.
    Richard P; Isnard R; Carrier L; Dubourg O; Donatien Y; Mathieu B; Bonne G; Gary F; Charron P; Hagege M; Komajda M; Schwartz K; Hainque B
    J Med Genet; 1999 Jul; 36(7):542-5. PubMed ID: 10424815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening Mutations of MYBPC3 in 114 Unrelated Patients with Hypertrophic Cardiomyopathy by Targeted Capture and Next-generation Sequencing.
    Liu X; Jiang T; Piao C; Li X; Guo J; Zheng S; Zhang X; Cai T; Du J
    Sci Rep; 2015 Jun; 5():11411. PubMed ID: 26090888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Fabry disease among hypertrophic cardiomyopathy of genetic origin].
    Bouvagnet P; Millat G; Rousson R; Gilbert G; Derumeaux G
    Rev Med Interne; 2010 Dec; 31 Suppl 2():S233-7. PubMed ID: 21211671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.